Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jun 7;11(12):3253.
doi: 10.3390/jcm11123253.

Vanishing Bile Duct Syndrome in an Adult Patient: Case Report and Review of the Literature

Affiliations
Case Reports

Vanishing Bile Duct Syndrome in an Adult Patient: Case Report and Review of the Literature

Paolo Izzo et al. J Clin Med. .

Abstract

Vanishing bile duct syndrome (VBDS) is a rare condition characterized by progressive loss, destruction, and disappearance of the intra-hepatic bile ducts, leading to cholestasis and ductopenia. The exact mechanism of development of VDBS has not been established yet. Diagnosis of VBDS mainly relies on clinical and disease related presentations, but liver biopsy is compulsory for diagnosis. Due to the low incidence reported in the literature, a standardized treatment of VDBS has not been established; hence, this rare condition must be managed at a tertiary liver referral center. Here, we report the management and treatment of VBDS of an 81-year-old woman without any history of exposure to antibiotics, neoplasms, etc.

Keywords: cholestasis; ductopenia; prednisolone; ursodeoxycholic acid; vanishing bile duct syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Combination or double image CT scan of the liver, without (blue arrow) and with (double blue arrow) contrast medium, which does not show significant alterations of the intra-hepatic vessels nor dilatations of the biliary ducts.
Figure 2
Figure 2
T2 weighted image (TR 2258 ms TE 100 ms) that does not show any alteration of caliber of the intrahepatic ducts (blue arrow).
Figure 3
Figure 3
Magnetic resonance cholangiopancreatography showing poor uptake of the contrast medium, especially on the left lobe of the liver (blue arrow).

References

    1. Nakanuma Y., Tsuneyama K., Harada K. Pathology and pathogenesis of intrahepatic bile duct loss. J. Hepatobiliary Pancreat. Surg. 2001;8:303–315. doi: 10.1007/s005340170002. - DOI - PubMed
    1. Reau N.S., Jensen D.M. Vanishing bile duct syndrome. Clin. Liver Dis. 2008;12:203–217. doi: 10.1016/j.cld.2007.11.007. - DOI - PubMed
    1. Gagnier J.J., Kienle G., Altman D.G., Moher D., Sox H., Riley D., CARE Group The CARE guidelines: Consensus-based clinical case reporting guideline development. BMJ Case Rep. 2013;2013:bcr2013201554. doi: 10.1136/bcr-2013-201554. - DOI - PMC - PubMed
    1. Ludwig J., Wiesner R.H., Batts K.P., Perkins J.D., Krom R.A.F. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation. Hepatology. 1987;7:476–483. doi: 10.1002/hep.1840070311. - DOI - PubMed
    1. Kita H., Matsumura S., He X.S., Ansari A.A., Lian Z.X., Van de Water J., Coppel R.L., Kaplan M.M., Gershwin M.E. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J. Clin. Investig. 2002;109:1231–1240. doi: 10.1172/JCI0214698. - DOI - PMC - PubMed

Publication types

LinkOut - more resources